Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Drug Discovery Today|April 4, 2006
Critical review of the role of HTS in drug discoveryRicardo MacarronCurrent Opinion in Chemical Biology|April 24, 2010
Enhancements of screening collections to address areas of unmet medical need: an industry perspectiveDavid H Drewry, Ricardo MacarronCurrent Drug Targets. Infectious Disorders|February 7, 2003
Novel antibacterials: a genomics approach to drug discoveryPan F Chan, Ricardo Macarron, David J Payne, et al.Journal of Biomolecular Screening|January 9, 2004
The effect of triton concentration on the activity of undecaprenyl pyrophosphate synthase inhibitorsHu Li, Jianzhong Huang, Xinhe Jiang, et al.Journal of Biomolecular Screening|January 28, 2009
Process validation and screen reproducibility in high-throughput screeningIsabel Coma, Liz Clark, Emilio Diez, et al.Nature Reviews. Drug Discovery|March 2, 2011
Impact of high-throughput screening in biomedical researchRicardo Macarron, Martyn N Banks, Dejan Bojanic, et al.The Journal of Pharmacology and Experimental Therapeutics|September 17, 2003
Identification of novel isoform-selective inhibitors within class I histone deacetylasesErding Hu, Edward Dul, Chiu-Mei Sung, et al.Journal of Biomolecular Screening|November 6, 2003
A standard operating procedure for assessing liquid handler performance in high-throughput screeningPaul B Taylor, Stephen Ashman, Stuart M Baddeley, et al.Journal of Medicinal Chemistry|February 7, 2024
Discovery of (4-Pyrazolyl)-2-aminopyrimidines as Potent and Selective Inhibitors of Cyclin-Dependent Kinase 2Joshua R Hummel, Kai-Jiong Xiao, Jeffrey C Yang, et al.The Journal of Biological Chemistry|August 9, 2002
Identification and biological characterization of heterocyclic inhibitors of the hepatitis C virus RNA-dependent RNA polymeraseDashyant Dhanak, Kevin J Duffy, Victor K Johnston, et al.Pageof 2